Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
4.850
+0.300 (6.59%)
Nov 24, 2025, 4:00 PM EST - Market closed
SONN Market Cap
SONN has a market cap or net worth of $33.11 million as of November 25, 2025. Its market cap has increased by 1,214.51% in one year.
Market Cap
33.11M
Enterprise Value
32.86M
1-Year Change
1,214.51%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $33.11M, a decrease of -43.01%. That is a compound annual growth rate of -9.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 33.11M | 654.13% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
| Apr 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |